• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Nordic Nanovector - Articles and news items

predosing-red-bone-marrow

Predosing NHL patients with lilotomab before betalutin therapy lowers haematological toxicity

Industry news / 5 September 2016 / Niamh Louise Marriott, Digital Content Producer

RM radiation doses were significantly higher in the patients who did not receive predosing, indicating that pre-dosing with lilotomab has a protective…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +